180 related articles for article (PubMed ID: 17013373)
1. Histopathological alterations in irritable bowel syndrome.
Kirsch R; Riddell RH
Mod Pathol; 2006 Dec; 19(12):1638-45. PubMed ID: 17013373
[TBL] [Abstract][Full Text] [Related]
2. The pathophysiology of irritable bowel syndrome.
Schwetz I; Bradesi S; Mayer EA
Minerva Med; 2004 Oct; 95(5):419-26. PubMed ID: 15467517
[TBL] [Abstract][Full Text] [Related]
3. Mucosal immune cell numbers and visceral sensitivity in patients with irritable bowel syndrome: is there any relationship?
Braak B; Klooker TK; Wouters MM; Welting O; van der Loos CM; Stanisor OI; van Diest S; van den Wijngaard RM; Boeckxstaens GE
Am J Gastroenterol; 2012 May; 107(5):715-26. PubMed ID: 22488080
[TBL] [Abstract][Full Text] [Related]
4. [The pathophysiology of irritable bowel syndrome: inflammation and motor disorder].
Park H
Korean J Gastroenterol; 2006 Feb; 47(2):101-10. PubMed ID: 16498275
[TBL] [Abstract][Full Text] [Related]
5. Irritable bowel syndrome: is the colonic mucosa to blame?
Hoffman JM
Neurogastroenterol Motil; 2012 Dec; 24(12):1051-3. PubMed ID: 23176660
[TBL] [Abstract][Full Text] [Related]
6. Transfer of CD11c+ lamina propria mononuclear phagocytes from post-infectious irritable bowel syndrome causes mucosal barrier dysfunction and visceral hypersensitivity in recipient mice.
Ren YJ; Zhang L; Bai T; Yu HL; Li Y; Qian W; Jin S; Xiong ZF; Wang H; Hou XH
Int J Mol Med; 2017 Jun; 39(6):1555-1563. PubMed ID: 28440501
[TBL] [Abstract][Full Text] [Related]
7. Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier.
Martínez C; Lobo B; Pigrau M; Ramos L; González-Castro AM; Alonso C; Guilarte M; Guilá M; de Torres I; Azpiroz F; Santos J; Vicario M
Gut; 2013 Aug; 62(8):1160-8. PubMed ID: 22637702
[TBL] [Abstract][Full Text] [Related]
8. Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome.
Cremon C; Carini G; Wang B; Vasina V; Cogliandro RF; De Giorgio R; Stanghellini V; Grundy D; Tonini M; De Ponti F; Corinaldesi R; Barbara G
Am J Gastroenterol; 2011 Jul; 106(7):1290-8. PubMed ID: 21427712
[TBL] [Abstract][Full Text] [Related]
9. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome.
Barbara G; Wang B; Stanghellini V; de Giorgio R; Cremon C; Di Nardo G; Trevisani M; Campi B; Geppetti P; Tonini M; Bunnett NW; Grundy D; Corinaldesi R
Gastroenterology; 2007 Jan; 132(1):26-37. PubMed ID: 17241857
[TBL] [Abstract][Full Text] [Related]
10. Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome.
Park JH; Rhee PL; Kim HS; Lee JH; Kim YH; Kim JJ; Rhee JC
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):71-8. PubMed ID: 16706815
[TBL] [Abstract][Full Text] [Related]
11. Inflammation in irritable bowel syndrome: Myth or new treatment target?
Sinagra E; Pompei G; Tomasello G; Cappello F; Morreale GC; Amvrosiadis G; Rossi F; Lo Monte AI; Rizzo AG; Raimondo D
World J Gastroenterol; 2016 Feb; 22(7):2242-55. PubMed ID: 26900287
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulation of enteric neural function in irritable bowel syndrome.
O'Malley D
World J Gastroenterol; 2015 Jun; 21(24):7362-6. PubMed ID: 26139983
[TBL] [Abstract][Full Text] [Related]
13. New insights into the pathogenesis and pathophysiology of irritable bowel syndrome.
Ohman L; Simrén M
Dig Liver Dis; 2007 Mar; 39(3):201-15. PubMed ID: 17267314
[TBL] [Abstract][Full Text] [Related]
14. Colonic mast cell numbers, symptom profile, and mucosal expression of elements of the epithelial barrier in irritable bowel syndrome.
Sundin J; Nordlander S; Eutamene H; Alquier-Bacquie V; Cartier C; Theodorou V; Le Nevé B; Törnblom H; Simrén M; Öhman L
Neurogastroenterol Motil; 2019 Nov; 31(11):e13701. PubMed ID: 31518490
[TBL] [Abstract][Full Text] [Related]
15. Is irritable bowel syndrome an inflammatory disorder?
De Giorgio R; Barbara G
Curr Gastroenterol Rep; 2008 Aug; 10(4):385-90. PubMed ID: 18627650
[TBL] [Abstract][Full Text] [Related]
16. Fructo-oligosaccharide intensifies visceral hypersensitivity and intestinal inflammation in a stress-induced irritable bowel syndrome mouse model.
Chen BR; Du LJ; He HQ; Kim JJ; Zhao Y; Zhang YW; Luo L; Dai N
World J Gastroenterol; 2017 Dec; 23(47):8321-8333. PubMed ID: 29307992
[TBL] [Abstract][Full Text] [Related]
17. Colonic mucosal mediators from patients with irritable bowel syndrome excite enteric cholinergic motor neurons.
Balestra B; Vicini R; Cremon C; Zecchi L; Dothel G; Vasina V; De Giorgio R; Paccapelo A; Pastoris O; Stanghellini V; Corinaldesi R; De Ponti F; Tonini M; Barbara G
Neurogastroenterol Motil; 2012 Dec; 24(12):1118-e570. PubMed ID: 22937879
[TBL] [Abstract][Full Text] [Related]
18. The role of mast cells in functional GI disorders.
Wouters MM; Vicario M; Santos J
Gut; 2016 Jan; 65(1):155-68. PubMed ID: 26194403
[TBL] [Abstract][Full Text] [Related]
19. Convergence of neuro-endocrine-immune pathways in the pathophysiology of irritable bowel syndrome.
Buckley MM; O'Mahony SM; O'Malley D
World J Gastroenterol; 2014 Jul; 20(27):8846-58. PubMed ID: 25083058
[TBL] [Abstract][Full Text] [Related]
20. A clinicopathologic study of 24 cases of systemic mastocytosis involving the gastrointestinal tract and assessment of mucosal mast cell density in irritable bowel syndrome and asymptomatic patients.
Doyle LA; Sepehr GJ; Hamilton MJ; Akin C; Castells MC; Hornick JL
Am J Surg Pathol; 2014 Jun; 38(6):832-43. PubMed ID: 24618605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
